Vanberra Signal

YamaYami

Curated by Signal

Developer of a smart device for local transdermal drug delivery and gene therapy

Overview

Developer of a smart device for local transdermal drug delivery and gene therapy. It offers a wearable smart patch based on iontophoresis technology for pediatric health track, transdermal vaccination, local gene therapy, and botulinum toxin delivery.

Key facts

Founded
2016

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of business management system for fitness studios

    Health TechnologyMoscow, Russia
  • Mobile-based application offering fitness membership programs

    Health TechnologyMoscow, Russia
  • Provider of fitness simulator devices to manage fitness

    Health TechnologyMoscow, Russia

About YamaYami

What does YamaYami do?

Developer of a smart device for local transdermal drug delivery and gene therapy.

Where is YamaYami headquartered?

YamaYami is headquartered in Saint Petersburg, Russia.

When was YamaYami founded?

YamaYami was founded in 2016.

Which sector is YamaYami in?

YamaYami operates in Health Technology.

Who are YamaYami's competitors?

Companies similar to YamaYami include Mobifitness, Fitnation, and Jobstick.